CALI.CN - FinCanna Capital Corp.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
0.275
-0.010 (-3.51%)
At close: 3:52PM EDT
Stock chart is not supported by your current browser
Previous Close0.285
Open0.000
Bid0.270 x 0
Ask0.285 x 0
Day's Range0.000 - 0.000
52 Week Range
Volume0
Avg. Volume212,723
Market Cap27.03M
Beta1.17
PE Ratio (TTM)N/A
EPS (TTM)-0.130
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire22 hours ago

    FinCanna Capital Welcomes John Campbell to its Advisory Board

    FinCanna Capital Corp. (“FinCanna”) (CSE:CALI) (FNNZF) a royalty company for the U.S. licensed medical cannabis industry, is pleased to announce the appointment of Mr. John Campbell to its Advisory Board. Mr. Campbell has over 35 years of experience in the investment industry, and currently serves as Chairman and CFO of TriView Capital, one of Canada’s largest Exempt Market Dealers. Mr. Campbell was formerly a Managing Director of private equity firm Second City Capital.

  • GlobeNewswire8 days ago

    FinCanna Investment, CTI Executes Exclusive Manufacturing and Distribution Agreement with Phoenix Tears for its THC Based Products in California

    FinCanna Capital Corp. (“FinCanna”) (CSE:CALI) (FNNZF) a royalty company for the U.S. licensed medical cannabis industry, reports that Cultivation Technologies Inc. (CTI) its first investment in California, announced today that it has executed an agreement with Phoenix Tears LLC, to be the exclusive manufacturer and distributer of official Phoenix Tears THC based products in California. Since its inception in 2010, Phoenix Tears—through its cannabis research and formulations—has supported more than 200,000 individuals through its brand and products which now resonate globally.

  • GlobeNewswire10 days ago

    FinCanna Executes & Increases Royalty Payments Under Agreement with Refined Resin Technologies Inc. a California Based Cannabis and Extraction Company

    FinCanna Capital Corp. (“FinCanna”) (CSE:CALI) (FNNZF) a royalty company for the U.S. licensed medical cannabis industry, has executed an Expanded Royalty Agreement with Refined Resin Technologies Inc. (“Refined Resin”) formerly known as Gram Co Holdings LLC, of Oakland, California. Refined Resin is a cannabinoid research and refinery company that provides B2B and B2C products and services to licensed dispensaries and distributors in the medical cannabis supply chain. FinCanna will fund US$3 million in tranches to complete the original Royalty Agreement transaction that was previously announced under a binding term sheet in February 2018.  In return, FinCanna will receive a tiered corporate royalty, ranging from 14% to 5.0% of Refined Resin’s annual revenues, based upon agreed upon benchmarks.

  • GlobeNewswire14 days ago

    FinCanna Closes Second and Final Tranche of Oversubscribed Private Placement for Total Proceeds of $6.8 million

    FinCanna Capital Corp. (“FinCanna”) (CSE:CALI) a royalty company for the U.S. licensed medical cannabis industry, announces that it has closed its second and final tranche of the oversubscribed private placement previously announced on June 15 and upsized on June 18, 27 and 29, 2018.  The Company issued an additional 2,270,422 Units at a price of $0.30 per unit for gross proceeds of $681,128. Each Unit consists of one common share of FinCanna and one common share purchase warrant.  Each full warrant will be exercisable to acquire one common share of FinCanna at an exercise price of $0.45 for 24 months from the date of the closing of the Private Placement.

  • GlobeNewswire17 days ago

    FinCanna Closes Oversubscribed Private Placement for $6.1 Million

    FinCanna Capital Corp. (“FinCanna”) (CSE:CALI) a royalty company for the U.S. licensed medical cannabis industry, announces that it has closed its oversubscribed private placement previously announced on June 15 and upsized on June 18, 27 and 29, 2018.  The Company issued 20,396,535 Units at a price of $0.30 per unit for gross proceeds of $6,118,961. The Company anticipates some additional funds to be received within the week and will close these additional units at that time. Each Unit consists of one common share of FinCanna and one common share purchase warrant.  Each full warrant will be exercisable to acquire one common share of FinCanna at an exercise price of $0.45 for 24 months from the date of the closing of the Private Placement.

  • GlobeNewswire21 days ago

    FinCanna Increases Private Placement to $6.1 Million

    FinCanna Capital Corp. (“FinCanna”) (CSE:CALI) a royalty company for the U.S. licensed medical cannabis industry is pleased to announce that following higher than anticipated demand the Company has increased the size of its previously announced non-brokered private placement financing. Initially announced at $3 million and subsequently raised to $5 million and $5.5 million, the Company has now increased its non-brokered private placement offering to $6.1 million. Each Unit will consist of one common share of FinCanna and one common share purchase warrant.

  • GlobeNewswire22 days ago

    Coverage Initiated for FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) via NetworkNewsWire

    FinCanna Capital Corp. (CSE:CALI) (FNNZF), a royalty company for the U.S. licensed medical cannabis industry, announces it has engaged the corporate communications expertise of NetworkNewsWire ("NNW"). FinCanna Capital is a royalty company aiming to be the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry. Primarily focused on the burgeoning California cannabis market, FinCanna leverages extensive investment expertise and industry experience to benefit its shareholders and portfolio companies.

  • GlobeNewswire23 days ago

    FinCanna Increases Private Placement to $5.5 Million

    FinCanna Capital Corp. (“FinCanna”) (CSE:CALI) a royalty company for the U.S. licensed medical cannabis industry is pleased to announce that following higher than anticipated demand the Company has increased the size of its previously announced non-brokered private placement financing. Initially announced at $3 million and subsequently raised to $5 million, the Company has now increased its non-brokered private placement offering to $5.5 million. Each Unit will consist of one common share of FinCanna and one common share purchase warrant.

  • GlobeNewswirelast month

    FinCanna Investee ezGreen Compliance On-Boards Multiple Customers across California, the largest Cannabis market in North America

    FinCanna Capital Corp. (“FinCanna”) (CSE:CALI) (FNNZF) a royalty company for the U.S. licensed medical cannabis industry, announces that its portfolio investee company, ezGreen Compliance (“ezGreen”), which offers a state-of-the-art enterprise compliance and point-of-sale (POS) software solution for licensed medical cannabis dispensaries and cultivators, has launched its pilot marketing program and has on-boarded multiple customers (dispensaries and cultivators) across the State of California. The pilot program customers are currently utilizing ezGreen’s Health Insurance Portability and Accountability Act (“HIPAA”)  Compliance Point-of-Sale Solution and inventory tracking system. Navigating through state-by-state license, tax and compliance issues has been challenging for the legal cannabis industry.

  • GlobeNewswirelast month

    Coverage Initiated for FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) via NetworkNewsWire

    NEW YORK, June 18, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – FinCanna Capital Corp. (CSE:CALI) (FNNZF), a royalty company for the U.S. licensed medical cannabis industry, announces it has engaged the corporate communications expertise of NetworkNewsWire ("NNW"). FinCanna is a royalty company aiming to be the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry. Primarily focused on the burgeoning California cannabis market, FinCanna leverages extensive investment expertise and industry experience to benefit its shareholders and portfolio companies.

  • GlobeNewswirelast month

    FinCanna Increases Private Placement to C$5 Million

    FinCanna Capital Corp. (“FinCanna”) (CSE:CALI) a royalty company for the U.S. licensed medical cannabis industry, is pleased to announce that following higher than anticipated demand the Company has increased the size of its previously announced non-brokered private placement financing from C$3 million to C$5 million. FinCanna will now issue up to 16,666,667 Units at a purchase price of C$0.30 per Unit. Each Unit will consist of one common share of FinCanna and one common share purchase warrant.

  • GlobeNewswirelast month

    FinCanna Capital Corp. Announces Non-Brokered Private Placement to Raise C$3 million

    FinCanna Capital Corp. (“FinCanna”) (CSE:CALI) is pleased to announce its intention to raise C$3,000,000 by way of a non-brokered private placement of 10,000,000 units (the “Units”) at a price of C$0.30 per Unit (the “Private Placement”). Each Unit will consist of one common share of FinCanna and one common share purchase warrant. Each full warrant will be exercisable to acquire one common share of FinCanna at an exercise price of C$0.45 for 24 months from the date of the closing of the Private Placement.

  • GlobeNewswirelast month

    CFN Exclusive Interview with FinCanna CEO Andriyko Herchak

    CFN Media recently sat down with FinCanna Capital Corp. (CSE:CALI) (FNNZF) CEO Andriyko Herchak to discuss the company’s royalty investment model, its accomplishments to date, and its strategy going forward. At FinCanna Capital we are building a diversified portfolio of royalty based income by investing in top tier companies in the United States medical cannabis industry, with a focus on California. Basically, we invest capital in a company and in exchange we receive a percentage of its revenue going forward.

  • GlobeNewswirelast month

    FinCanna Investee ezGreen Compliance launches ezGreen 2.0 to Manage Cannabis Compliance with HIPAA Certified Patient Data Protection Measures

    FinCanna Capital Corp. (“FinCanna”) (CSE:CALI) (FNNZF) a royalty company for the U.S. licensed medical cannabis industry announces that its portfolio investee company, ezGreen Compliance (“ezGreen”), which offers a state-of-the-art enterprise compliance and point-of-sale (POS) software solution for licensed medical cannabis dispensaries and cultivators, has launched its advanced “ezGreen Compliance 2.0” software solution. Additionally, ezGreen has executed a strategic partnership agreement with a major technology solution provider in the cannabis industry to offer the ezGreen Compliance solution to its customer base of 1,000+ dispensaries across the United States.

  • GlobeNewswirelast month

    FinCanna Flagship Investment, CTI Reaches First $1M USD in Cannabis Extraction Revenue

    FinCanna Capital Corp. (“FinCanna”) (CSE:CALI) (FNNZF) a royalty company for the U.S. licensed medical cannabis industry, announced today that Cultivation Technologies Inc., (CTI) its first investment in California, has achieved US$1 million in cumulative revenue since it commenced commercial operations in late January 2018. FinCanna announced previously this week that CTI has expanded its network of dispensaries carrying Coachella™ Premium brand of cannabis concentrates and vape cartridges which features all the major concentrate types, including diamonds, sauce, shatter, batter, and sugar, with an ongoing list of strains, to ten locations including premium dispensaries across California.

  • GlobeNewswire2 months ago

    FinCanna’s Investment, Cultivation Technologies, Secures Distribution Across California and Commenced Sales of its Coachella™ Premium Cannabis Concentrates and Vape Cartridges

    VANCOUVER, British Columbia, June 04, 2018-- FinCanna Capital Corp., a royalty company for the U.S. licensed medical cannabis industry, provides the following update on Cultivation Technologies, Inc., ...